Blood
Oral anticoagulants (warfarin and the direct oral anticoagulants)
Tablets that prevent clots: warfarin blocks the vitamin K cycle; the direct oral anticoagulants (DOACs) inhibit thrombin or factor Xa. Used for venous thromboembolism and to prevent stroke in atrial fibrillation.
طریقۂ عمل
- Factors II, VII, IX and X need vitamin K to become active (γ-carboxylation).
- Warfarin inhibits vitamin K epoxide reductase (VKORC1), so the liver makes inactive factors; its effect takes days and is monitored with the INR.
- Dabigatran inhibits thrombin directly; apixaban, rivaroxaban and edoxaban inhibit factor Xa directly. Their effect is immediate and predictable.
Molecular targets
- Vitamin K epoxide reductase (VKORC1): Inhibitor (warfarin)
- Factor Xa: Direct inhibitor (apixaban, rivaroxaban)
- Thrombin: Direct inhibitor (dabigatran)
Oral anticoagulants (warfarin and the direct oral anticoagulants) کی ادویات
Vitamin K antagonist
- Warfarin (Vitamin K antagonist; many drug and food interactions; reversed by vitamin K.)
Direct factor Xa inhibitors
- Apixaban (Factor Xa inhibitor.)
- Rivaroxaban (Factor Xa inhibitor.)
Direct thrombin inhibitor
- Dabigatran (Direct thrombin inhibitor; reversed by idarucizumab.)
علاج میں استعمال
- Treatment and secondary prevention of deep vein thrombosis and pulmonary embolism
- Preventing stroke and systemic embolism in atrial fibrillation, which commonly accompanies mitral valve disease
- Mechanical heart valves: warfarin only
جن بیماریوں کا علاج کرتی ہے
مضر اثرات
- Bleeding, the main risk
- Warfarin: skin necrosis early in treatment; birth defects
حالت کے لحاظ سے ممانعت
- Pregnancy (warfarin) (ممنوع): Warfarin crosses the placenta and causes birth defects and fetal bleeding; heparins are used instead.
- Peptic ulcer disease (ممنوع): Anticoagulation prevents the bleeding point from sealing.
- Rheumatic heart disease (ممنوع): DOACs failed to prevent valve thrombosis; warfarin is used.
- Liver cirrhosis (احتیاط سے): The liver already makes fewer clotting factors and clears these drugs less well: bleeding risk rises.
- Kidney impairment (DOACs) (احتیاط سے): Dabigatran in particular is cleared by the kidney and accumulates.
دیگر احتیاطیں اور interactions
- Warfarin’s effect is raised by drugs that inhibit CYP2C9 (amiodarone, metronidazole, fluconazole) and lowered by inducers such as rifampicin.
جڑے ہوئے موضوعات
ماخذ
- Lippincott Illustrated Reviews: Pharmacology, 7th ed., Ch. 21, Anticoagulants and Antiplatelet Agents, Oral anticoagulants
- Basic & Clinical Pharmacology (Katzung), 14th ed., Ch. 34, Drugs Used in Disorders of Coagulation, Warfarin & other coumarin anticoagulants; direct oral anticoagulants
تعلیمی حوالہ۔ طبی مشورہ، تشخیص یا علاج نہیں۔